As a potential diagnostic biomarker, the detection of the TRIM protein is of great significance; in addition to helping to evaluate the progression and prognosis of liver disease, it can also be used to detect drug therapy effect and advance preventive screening [13]. This evidence concerns the gene TRAT1 and liver disorder.